Yahoo
NasdaqGS - Delayed Quote USD

Bruker Corporation (BRKR)

61.31 +3.25 (+5.60%)
At close: November 6 at 4:00:01 PM EST
61.31 0.00 (0.00%)
After hours: November 6 at 4:00:30 PM EST
Trade Bruker on Coinbase
Chart Range Bar
Loading chart for BRKR
  • Previous Close 58.06
  • Open 59.00
  • Bid 58.53 x 100
  • Ask 64.86 x 100
  • Day's Range 58.46 - 61.66
  • 52 Week Range 32.37 - 68.98
  • Volume 2,012,718
  • Avg. Volume 2,279,504
  • Market Cap (intraday) 9.363B
  • Beta (5Y Monthly) 1.27
  • PE Ratio (TTM) --
  • EPS (TTM) -1.10
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 0.20 (0.33%)
  • 1y Target Est 67.33
  • Moby Rating Bear

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

www.bruker.com

11,085

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BRKR
30.56%
S&P 500 (^GSPC)
7.76%

1-Year Return

BRKR
56.63%
S&P 500 (^GSPC)
9.77%

3-Year Return

BRKR
10.49%
S&P 500 (^GSPC)
68.96%

5-Year Return

BRKR
23.57%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 874M
Earnings -122.8M
Profit Margin -14.05%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

55.00 Low
67.33 Average
61.31 Current
85.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/5/2026
Analyst Citigroup
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 53 -> 64

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.51%

  • Return on Assets (ttm)

    3.28%

  • Return on Equity (ttm)

    -4.79%

  • Revenue (ttm)

    3.51B

  • Net Income Avi to Common (ttm)

    -167.3M

  • Diluted EPS (ttm)

    -1.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    119.7M

  • Total Debt/Equity (mrq)

    74.14%

  • Levered Free Cash Flow (ttm)

    204.3M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: